Lufuradom

In today's world, Lufuradom has become a topic of increasing interest and debate. As society advances, the different perspectives and discussions around Lufuradom have led to greater awareness and understanding of its importance. Whether through technological advances, cultural changes or scientific discoveries, Lufuradom has captured the attention of experts and the general public. In this article, we will explore different aspects related to Lufuradom and how it has impacted and will continue to impact various aspects of our lives.
Lufuradom
Clinical data
ATC code
  • None
Identifiers
  • N--3-furamide
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC22H20FN3O2
Molar mass377.419 g·mol−1
3D model (JSmol)
  • O=C(C1=COC=C1)NCC2N(C)C3=C(C(C4=CC=CC=C4)=NC2)C=CC(F)=C3
  • InChI=1S/C22H20FN3O2/c1-26-18(13-25-22(27)16-9-10-28-14-16)12-24-21(15-5-3-2-4-6-15)19-8-7-17(23)11-20(19)26/h2-11,14,18H,12-13H2,1H3,(H,25,27)
  • Key:QJSCDZOUCFWCKD-UHFFFAOYSA-N

Lufuradom (INN) is a drug and benzodiazepine derivative which, unlike other benzodiazepines, is described as an analgesic.[1] Similarly to its analogue tifluadom, it was never marketed.

See also

  • Tifluadom
  • GYKI-52895, structural benzodiazepine which is a dopamine reuptake inhibitor without GABAergic function
  • GYKI-52,466, structural benzodiazepine which is an AMPAkine and glutamate antagonist without GABAergic function

References

  1. ^ World Health Organization (31 December 1988). International nonproprietary names (INN) for pharmaceutical substances, 1988: lists 1-58 of proposed INN and lists 1-27 of recommended INN : cumulative list. World Health Organization. p. 252. ISBN 978-92-4-056014-7. Retrieved 26 April 2012.



Stub icon

This analgesic-related article is a stub. You can help Wikipedia by expanding it.

Wikious
Boobota
Sagapedia